DEF 14A

Company

Jaguar Health, Inc.

Filed

November 10, 2025

Period of Report

December 8, 2025

Accession Number

0001193125-25-274382

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →